Kennedy-Wilson Stock Forecast, Price & News

Kennedy-Wilson (NYSE:KW) Frequently Asked Questions

Is Kennedy-Wilson a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kennedy-Wilson in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Kennedy-Wilson stock.
View analyst ratings for Kennedy-Wilson or view top-rated stocks.

How has Kennedy-Wilson's stock been impacted by Coronavirus?

Kennedy-Wilson's stock was trading at $17.03 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, KW shares have increased by 32.7% and is now trading at $22.60.
View which stocks have been most impacted by COVID-19.

When is Kennedy-Wilson's next earnings date?

Kennedy-Wilson is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Kennedy-Wilson.

How were Kennedy-Wilson's earnings last quarter?

Kennedy-Wilson Holdings, Inc. (NYSE:KW) released its quarterly earnings results on Wednesday, November, 3rd. The financial services provider reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.06. The financial services provider earned $114.40 million during the quarter, compared to analyst estimates of $112.11 million. Kennedy-Wilson had a net margin of 107.98% and a trailing twelve-month return on equity of 45.77%. During the same period in the prior year, the firm posted $0.16 earnings per share.
View Kennedy-Wilson's earnings history.

How often does Kennedy-Wilson pay dividends? What is the dividend yield for Kennedy-Wilson?

Kennedy-Wilson announced a quarterly dividend on Wednesday, November 3rd. Stockholders of record on Friday, December 31st will be paid a dividend of $0.24 per share on Thursday, January 6th. This represents a $0.96 annualized dividend and a yield of 4.25%. The ex-dividend date is Thursday, December 30th. This is an increase from Kennedy-Wilson's previous quarterly dividend of $0.22.
View Kennedy-Wilson's dividend history.

Is Kennedy-Wilson a good dividend stock?

Kennedy-Wilson pays an annual dividend of $0.88 per share and currently has a dividend yield of 3.76%. Kennedy-Wilson has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Kennedy-Wilson is 27.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Kennedy-Wilson will have a dividend payout ratio of 52.69% next year. This indicates that Kennedy-Wilson will be able to sustain or increase its dividend.
View Kennedy-Wilson's dividend history.

What price target have analysts set for KW?

2 analysts have issued 1 year price objectives for Kennedy-Wilson's shares. Their forecasts range from $24.00 to $26.00. On average, they anticipate Kennedy-Wilson's stock price to reach $25.00 in the next twelve months. This suggests a possible upside of 10.6% from the stock's current price.
View analysts' price targets for Kennedy-Wilson or view top-rated stocks among Wall Street analysts.

Who are Kennedy-Wilson's key executives?

Kennedy-Wilson's management team includes the following people:

• William J. McMorrow, Chairman & Chief Executive Officer
• Mary L. Ricks, President & Director
• Justin Enbody, CFO & Principal Accounting Officer
• Kent Y. Mouton, Director, Executive VP & General Counsel
• Matthew Windisch, Executive Vice President

What is William J. McMorrow's approval rating as Kennedy-Wilson's CEO?

19 employees have rated Kennedy-Wilson CEO William J. McMorrow on Glassdoor.com. William J. McMorrow has an approval rating of 63% among Kennedy-Wilson's employees. This puts William J. McMorrow in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Kennedy-Wilson's key competitors?

Some companies that are related to Kennedy-Wilson include Gecina (GECFF), Hang Lung Properties (HLPPY), FirstService (FSV), Land Securities Group (LSGOF), Innovative Industrial Properties (IIPR), Colliers International Group (CIGI), Terreno Realty (TRNO), Cushman & Wakefield (CWK), Hudson Pacific Properties (HPP), New World Development (NDVLY), Urban Edge Properties (UE), Shanghai Industrial (SGHIY), Gazit Globe (GZTGF), Getty Realty (GTY) and SOHO China (SOHOF).
View all of KW's competitors.

What other stocks do shareholders of Kennedy-Wilson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kennedy-Wilson investors own include Verizon Communications (VZ), Bank of America (BAC), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Johnson & Johnson (JNJ), AT&T (T) and QUALCOMM (QCOM).

What is Kennedy-Wilson's stock symbol?

Kennedy-Wilson trades on the New York Stock Exchange (NYSE) under the ticker symbol "KW."

Who are Kennedy-Wilson's major shareholders?

Kennedy-Wilson's stock is owned by a number of institutional and retail investors. Top institutional investors include Fairfax Financial Holdings Ltd Can (9.24%), BlackRock Inc. (8.67%), Principal Financial Group Inc. (4.62%), Mackenzie Financial Corp (3.05%), Dimensional Fund Advisors LP (2.79%) and Goldman Sachs Group Inc. (2.18%). Company insiders that own Kennedy-Wilson stock include Cathy Hendrickson, Justin Enbody, Kent Y Mouton, Stanley R Zax and William J Mcmorrow.
View institutional ownership trends for Kennedy-Wilson.

Which institutional investors are selling Kennedy-Wilson stock?

KW stock was sold by a variety of institutional investors in the last quarter, including Ranger Global Real Estate Advisors LLC, BlackRock Inc., Fairfax Financial Holdings Ltd Can, TimesSquare Capital Management LLC, Principal Financial Group Inc., Victory Capital Management Inc., Geode Capital Management LLC, and Renaissance Technologies LLC. Company insiders that have sold Kennedy-Wilson company stock in the last year include Justin Enbody, and Kent Y Mouton.
View insider buying and selling activity for Kennedy-Wilson or view top insider-selling stocks.

Which institutional investors are buying Kennedy-Wilson stock?

KW stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Millennium Management LLC, Dimensional Fund Advisors LP, Jennison Associates LLC, Richard Bernstein Advisors LLC, SG Americas Securities LLC, Hillsdale Investment Management Inc., and Virginia Retirement Systems ET AL. Company insiders that have bought Kennedy-Wilson stock in the last two years include Stanley R Zax, and William J Mcmorrow.
View insider buying and selling activity for Kennedy-Wilson or or view top insider-buying stocks.

How do I buy shares of Kennedy-Wilson?

Shares of KW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kennedy-Wilson's stock price today?

One share of KW stock can currently be purchased for approximately $22.60.

How much money does Kennedy-Wilson make?

Kennedy-Wilson has a market capitalization of $3.15 billion and generates $450.90 million in revenue each year. The financial services provider earns $110.10 million in net income (profit) each year or $3.17 on an earnings per share basis.

How many employees does Kennedy-Wilson have?

Kennedy-Wilson employs 202 workers across the globe.

What is Kennedy-Wilson's official website?

The official website for Kennedy-Wilson is www.kennedywilson.com.

Where are Kennedy-Wilson's headquarters?

Kennedy-Wilson is headquartered at 151 S EL CAMINO DRIVE, BEVERLY HILLS CA, 90212.

How can I contact Kennedy-Wilson?

Kennedy-Wilson's mailing address is 151 S EL CAMINO DRIVE, BEVERLY HILLS CA, 90212. The financial services provider can be reached via phone at (310) 887-6400, via email at [email protected], or via fax at 310-887-3410.